TEXAS -- The nurse wore a mask, gown, shield and gloves as she helped care for a
dying Ebola patient in Texas.
And a day after the Centers for Disease
Control and Prevention said she tested positive for Ebola, health officials are
still trying to figure out how exactly she caught it.
"Something went wrong, and we need to
find out why and what," said Dr. Anthony Fauci, director of the National
Institute of Allergy and Infectious Diseases.
The woman, Nina Pham, took basic precautions
while treating Ebola-stricken Liberian national Thomas Eric Duncan at a Dallas
hospital. Now she is the first person to have contracted the deadly virus in
the United States.
There are few details that are known about
what might have gone wrong.
On Monday, Dr. Tom Frieden, director of the
CDC, told reporters that it's still unknown how the infection occurred, only
that a "breach in protocol" for treating a patient happened.
Frieden said state and federal health
officials are re-examining those protocols, including the removal of protective
gear after contact with an Ebola patient and if it might be helpful to spray
virus-killing solution on workers as they leave an isolation unit. He said
Monday that the nurse is "clinically stable."
On Monday, she got a blood transfusion from
American Ebola survivor Kent Brantly, according to Jeremy Blume, a spokesman
for Samaritan's Purse. Brantly was working for Samaritan's Purse in Liberia
when he contracted the virus.
Pham, 26, graduated from Texas Christian
University's nursing program in 2010, WFAA reported. According to the website
for the American Association of Critical Care Nurses, she received certification
in critical care nursing on August 1, less than two months before she began
caring for Duncan.
Tom Ha, a family friend, described Pham as a
devout Catholic who always "puts other people's interests ahead of her
own." It's a philosophy she shares with her family, he told CNN.
"They always helped other people and
they take pride in helping other people," he said. "That's what this
family's all about."
No comments:
Post a Comment